Canadian Urological Association / L'Association des urologues du Canada

Canadian Urological Association (CUA)

Health EN ↓ Odcinki: 102

The official podcast of the Canadian Urological Association (CUA).Le podcast officiel de l'association des urologues du Canada (AUC).

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: cua.simplecast.com

Autor

Canadian Urological Association / L'Association des urologues du Canada

Kategoria

Health

Strona podcastu

cua.simplecast.com

Ostatni odcinek

4 mar 2025

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens 04.03.2025

Episode Notes Podcast Host Disclosures: Dr. Black has received honoraria from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Biosyent, Bristol- Myers Squibb, EMD-Serono, Ferring, Janssen Oncology, Merck, Nanology, Nonagen, Pfizer, Prokarium, Protara, QED, Roche Canada, Sanofi Canada, STIMIT, Urogen Pharma and Verity Dr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Ei...

Canadian Expert discussion on optimizing RCC treatment 29.11.2023

Episode Notes Podcast Host Disclosures: Dr. Choueiri reports institutional and/or personal, paid and/or unpaid support for research, advisory boards, consultancy, and/or honoraria from: Alkermes, AstraZeneca, Aravive, Aveo, Bayer, Bristol Myers-Squibb, Calithera, Circle Pharma, Eisai, EMD Serono, Exelixis, GlaxoSmithKline, Gilead, IQVA, Infinity, Ipsen, Jansen, Kanaph, Lilly, Merck, Nikang, Nuscan...

2 Pees In A Pod Podcast - Ep 4 - Introduction to bladder cancer 19.10.2023

The fourth episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features an introductory discussion on bladder cancer. Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com References from the show: Bladder Cancer Canada Disclaimer: The information provided in this podcast is for general infor...

2 Pees In A Pod Podcast - Ep 3 - Urinary tract infections in women 11.10.2023

The third episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on urinary tract infections in women. Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com Disclaimer: The information provided in this podcast is for general informational purposes only and is not intended a...

2 Pees In A Pod Podcast - Ep 2 - Male voiding disorders and Benign Prostatic Hyperplasia (BPH) 04.10.2023

The second episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features a discussion on male voiding disorders and Benign Prostatic Hyperplasia (BPH). Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com References from the show: CUA BPH Guidelines - Google Search Welcome to Canadian Urologi...

2 Pees In A Pod Podcast - Ep 1 - PSA and Prostate Cancer Screening 27.09.2023

Our inaugural 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz! This first podcast in the series focuses on PSA and Prostate Cancer Screening. Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.com References from the show: UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and e...

CUA Highlights of ESMO 2022 - Kidney Cancer Session - French 01.10.2022

Program Chair: Ricardo Rendon Kidney Cancer Panelists: Melissa Huynh, Lori Wood   Sponsors: Gold: Bristol Myers Squibb, Merck Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

CUA Highlights of ESMO 2022 - Kidney Cancer Session - English 01.10.2022

Program Chair: Ricardo Rendon Kidney Cancer Panelists: Melissa Huynh, Lori Wood   Sponsors: Gold: Bristol Myers Squibb, Merck Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

CUA Highlights of ESMO 2022 - Bladder Cancer Session - French 01.10.2022

Program Chair: Ricardo Rendon Bladder Cancer Panelists: Peter Black, Maria Jiang   Sponsors: Gold: Bristol Myers Squibb, Merck Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

CUA Highlights of ESMO 2022 - Bladder Cancer Session - English 01.10.2022

Program Chair: Ricardo Rendon Bladder Cancer Panelists: Peter Black, Maria Jiang   Sponsors: Gold: Bristol Myers Squibb, Merck Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

CUA Highlights of ESMO 2022 - Prostate Cancer Session - French 01.10.2022

Program Chair: Ricardo Rendon Prostate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan   Sponsors: Gold: Bristol Myers Squibb, Merck Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

CUA Highlights of ESMO 2022 - Prostate Cancer Session - English 01.10.2022

Program Chair: Ricardo Rendon Prostate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan   Sponsors: Gold: Bristol Myers Squibb, Merck Silver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen

Darryl Leong | CV Risk | Q&A Series 21.04.2022

Darryl Leong, MD McMaster University

Jean Gregoire | CV Risk | Q&A Series - French 21.04.2022

Jean Gregoire, MD, FRCP(C), FCCS, FACC, FACP University of Montreal Institut de cardiologie de Montreal

Fred Saad | CV Risk | Q&A Series - French 21.04.2022

Fred Saad, MD, FRCS CHUM, Institut de cancer de Montreal/CRCHUM

Fred Saad | CV Risk | Q&A Series 21.04.2022

Fred Saad, MD, FRCS CHUM, Institut de cancer de Montreal/CRCHUM

Jean Gregoire | CV Risk | Q&A Series 21.04.2022

Jean Gregoire, MD, FRCP(C), FCCS, FACC, FACP University of Montreal Institut de cardiologie de Montreal

Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series 20.04.2022

Sponsored by Amgen. Luke Lavallee Urologic Oncologist and Associate Scientist The Ottawa Hospital Ottawa Hospital Research Institute Disclosures: Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas Grant/Honorarium: Sanofi

Sophie Mottard | Bone Health Management in Prostate Cancer | Q&A Series 20.04.2022

Sponsored by Amgen. Sophie Mottard Orthopedic Oncology Surgeon Maisonneuve-Rosemont Hospital CHU Saint-Justine and Santa Cabrini Hospital Disclosures: Payment: Amgen (conference speaker)

David Kendler | Bone Health Management in Prostate Cancer | Q&A Series 20.04.2022

Sponsored by Amgen. David Kendler Endocrinologist and Clinical Professor UBC Disclosures: Advisory Board: Amgen, Paladin, Biosynt Speakers Bureau: Amgen Payment: Amgen, Biosynt, Radius Pharma, Paladin Grant/Honorarium: Amgen, Biosynt, Radius Pharma, Paladin Clinical Trial: Radius Pharma Leadership/Board Position: Specialists of BC, Drs. of BC section of Endocrinology (executive)  

Why the Tm:Fibre Laser is Superior to the Ho:YAG for Urinary Stones - French 20.04.2022

Disclosures: Hassan Razvi Patent: Cook Urological Clinical Trials: Boston Scientific, Verity Pharma Leadership/board position: AUA, Endourology Society Olivier Traxer Consultant: Karl Storz, Coloplast, IPG Medical, ROCAMED, Boston Scientific, Quanta, AMBU  

Why the Tm:Fibre Laser is Superior to the Ho:YAG for Urinary Stones 20.04.2022

Disclosures: Hassan Razvi Patent: Cook Urological Clinical Trials: Boston Scientific, Verity Pharma Leadership/board position: AUA, Endourology Society Olivier Traxer Consultant: Karl Storz, Coloplast, IPG Medical, ROCAMED, Boston Scientific, Quanta, AMBU

CUA Highlights of GU ASCO 2022 - Prostate Cancer Session 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Tamim Niazi Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolm...

CUA Highlights of GU ASCO 2022 - Bladder Cancer Session 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Nimira Alimohamed Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen Wassim Kassouf No disclosures Alejandro Berlin No disclosu...

CUA Highlights of GU ASCO 2022 - Kidney Cancer Session 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Christian Kollmannsberger Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer Honoraria for presentations: Pfizer, Ipsen, Eisa...

Słuchaj podcastu Canadian Urological Association (CUA) w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS